Pfizer Inc. (PREVNAR 20®)
(https://prevnar.com) 📸 Data Snapshot: June 19, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is well-established through robust Schema.org implementation identifying Pfizer Inc. as the publisher and manufacturer. No gaps exist in identity; the site links to a verified Medical Information contact point and provides a non-proprietary drug name in the metadata. The technical implementation of the heading hierarchy and structured data is clean and professional.
There is no disconnect between claims and demonstrations; the site claims protection against 20 strains and identifies those strains via the technical non-proprietary name. It does not over-promise ‘cures’ but focuses on the measurable outcome of ‘protection.’ The presence of a link to official prescribing information bridges the gap between marketing headlines and clinical reality.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"@id": "https://www.prevnar20.com/#organization",
"name": "Pfizer Inc.",
"url": "https://www.prevnar20.com/",
"logo": "https://www.pfizer.com/profiles/pfecpfizercomus_profile/themes/pfecpfizercomus/public/assets/images/logo-blue.svg",
"contactPoint": [
{
"@type": "ContactPoint",
"contactType": "Medical Information",
"telephone": "+1-800-438-1985",
"areaServed": "US",
"availableLanguage": "en"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.prevnar20.com/#website",
"url": "https://www.prevnar20.com/",
"name": "PREVNAR 20®",
"description": "The Prevnar 20 vaccine provides protection against pneumococcal disease for adults and babies.",
"publisher": {
"@id": "https://www.prevnar20.com/#organization"
},
"inLanguage": "en"
},
{
"@type": "MedicalTherapy",
"@id": "https://www.prevnar20.com/#therapy",
"name": "PREVNAR 20® (Pneumococcal 20-valent Conjugate Vaccine)",
"alternateName": "Prevnar 20®",
"relevantSpecialty": [
{
"@type": "MedicalSpecialty",
"name": "Infectious Disease"
},
{
"@type": "MedicalSpecialty",
"name": "Immunology"
},
{
"@type": "MedicalSpecialty",
"name": "Pediatrics"
},
{
"@type": "MedicalSpecialty",
"name": "Primary Care"
},
{
"@type": "MedicalSpecialty",
"name": "Preventive Medicine"
}
],
"drug": {
"@type": "Drug",
"@id": "https://www.prevnar20.com/#drug",
"name": "PREVNAR 20®",
"nonProprietaryName": "pneumococcal 20-valent conjugate vaccine",
"description": "Helps protect eligible adults against 20 different strains of the bacteria that cause pneumococcal pneumonia and invasive pneumococcal disease (IPD). Helps protect babies against 20 different strains of the bacteria that cause invasive pneumococcal disease (IPD).",
"drugClass": {
"@type": "DrugClass",
"name": "Vaccine"
},
"manufacturer": {
"@id": "https://www.prevnar20.com/#organization"
},
"prescribingInfo": "https://labeling.pfizer.com/ShowLabeling.aspx?id=15428",
"image": "https://adult.prevnar20.com/assets/icons/prevnar20.png",
"offers": {
"@type": "Offer",
"price": "0",
"priceCurrency": "USD",
"url": "https://www.pfizerrxpathways.com/"
}
}
},
{
"@type": "MedicalCondition",
"@id": "https://www.prevnar20.com/#condition",
"name": "Pneumococcal disease",
"description": "Pneumococcal disease includes pneumococcal pneumonia and invasive pneumococcal disease (IPD).",
"possibleTreatment": {
"@id": "https://www.prevnar20.com/#therapy"
},
"relevantSpecialty": [
{
"@type": "MedicalSpecialty",
"name": "Infectious Disease"
},
{
"@type": "MedicalSpecialty",
"name": "Immunology"
},
{
"@type": "MedicalSpecialty",
"name": "Pediatrics"
},
{
"@type": "MedicalSpecialty",
"name": "Primary Care"
},
{
"@type": "MedicalSpecialty",
"name": "Preventive Medicine"
}
]
},
{
"@type": "MedicalWebPage",
"@id": "https://www.prevnar20.com/#webpage",
"url": "https://www.prevnar20.com/",
"name": "PREVNAR 20® (Pneumococcal 20-Valent Conjugate Vaccine) | Safety Info",
"headline": "The Prevnar 20 vaccine provides protection against pneumococcal disease for adults and babies.",
"description": "FOR ADULTS: Helps protect eligible adults against 20 different strains of the bacteria that cause pneumococcal pneumonia and invasive pneumococcal disease (IPD). FOR BABIES: Helps protect your baby against 20 different strains of the bacteria that cause invasive pneumococcal disease (IPD).",
"author": {
"@id": "https://www.prevnar20.com/#organization"
},
"publisher": {
"@id": "https://www.prevnar20.com/#organization"
},
"isPartOf": {
"@id": "https://www.prevnar20.com/#website"
},
"about": [
{
"@id": "https://www.prevnar20.com/#therapy"
}
],
"audience": "https://health-lifesci.schema.org/Patient",
"inLanguage": "en"
}
]
}
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
This page presents a snapshot of public data from Pfizer Inc. (PREVNAR 20®), captured on June 19, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Pfizer Inc. (PREVNAR 20®): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://prevnar.com to view the most current version of its content and see directly what this company is about and what it offers.